Lupin’s Q3 profit meets estimates as India sales rise

Friday, February 5th, 2016 | by
MUMBAI (Reuters) - Lupin Ltd, India's third-largest drugmaker, reported a 12 percent fall in third-quarter profit that was in line with analysts' expectations, as strong sales in domestic market partially offset weak performance in the United States.

Short URL:

Comments are closed.


    • Should B.S Yaddyurappa become BJP Karnataka Presidant

      View Results

      Loading ... Loading ...
  • Popular Posts

    © 2012 IndiaWires. All Rights Reserved. Log in

    Designed & Maintained By Pyrumas

    Subscribe Newsletter